MARTIN MARIETTA MATERIALS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data MARTIN MARIETTA MATERIALS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	3,819	3,966	4,244	4,739	4,730	5,414	6,161	5,851	5,662	6,150
Cost of revenue	2,907	2,994	3,278	3,560	3,477	4,066	4,738	4,106	4,026	4,261
Gross profit	912	972	967	1,179	1,253	1,348	1,423	1,745	1,636	1,889
Selling, general and administrative	242	262	281	303	306	351	397	425	429	443
Operating income	677	700	691	885	1,005	974	1,207	1,333	2,479	1,437
Interest expense	81.7	91.5	137	129	118	143	169	165	169	230
Other non-operating income	11.4	10	22.5	-7.3	2	24.4	53	58	56	19
Pre-tax income	607	619	576	748	889	856	1,091	1,226	2,366	1,226
Income tax	182	-94.5	106	136	168	153	235	234	550	236
Income from continuing operations	425	713		612	721	702	856	1,200
Net income to minority interests	0.06	0.1	0.4	0.1	0.1	0.3	0	1	1	0
Net income	425	713	470	612	721	703	867	1,169	1,995	1,137
EBITDA	963	998	1,035	1,256	1,399	1,426	1,713	1,846	3,052	2,074
EPS, basic	6.66	11.30	7.46	9.77	11.56	11.26	13.91	18.88	32.50	18.81
EPS, diluted	6.63	11.25	7.43	9.74	11.54	11.22	13.87	18.82	32.41	18.77
Shares, basic (weighted)	63.6	62.9	62.9	62.5	62.3	62.4	62.3	61.9	61.4	60.5
Shares, diluted (weighted)	63.9	63.2	63.1	62.7	62.4	62.6	62.5	62.1	61.6	60.6
Dividend per share	1.72	1.72	1.84	2.06	2.24	2.36	2.54	2.80	3.06	3.24

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	50	1,446	44.9	21	207	258	358	1,272	670	67
Receivables		487	523	574	575	774	786	753	678	723
Inventory	522	601	663	691	709	753	874	989	1,018	1,078
Other current assets	56.8	97	135	141	70	138	80.7	88	68	95
Total current assets	1,086	2,631	1,366	1,427	1,668	2,026	2,877	3,919	2,449	3,193
Property, plant and equipment	3,423	3,593	5,157	5,206	5,242	6,338	6,317	6,186	9,660	10,290
Lease right-of-use assets				482	453	427	384	372	366	367
Goodwill	2,159	2,160	2,399	2,397	2,414	3,494	3,649	3,389	3,393	3,614
Intangible assets	483	472	472	459	472	1,029	812	664	62	8
Other non-current assets	120	102	128	133	295	426	547	561	646	788
Total assets	7,301	8,993	9,551	10,132	10,581	14,393	14,994	15,125	18,170	18,711
Accounts payable	179	184	211	230	208	356	385	343	375	389
Accrued liabilities	47.4	44.3	51.4			86.6	71.6	102	73	100
Short-term debt	180	300	390	340		0.1	699	400	125	30
Total current liabilities	547	694	787	839	499	753	1,446	1,170	1,002	895
Long-term debt	1,506	2,727	2,730	2,434	2,626	5,101	4,341	3,946	5,288	5,293
Lease liabilities				434	410	379	336	327	327	320
Other non-current liabilities	194	234	379	339	371	674	385	389	928	903
Total liabilities	3,158	4,310	4,602	4,778	4,688	7,855	7,821	7,089	8,714	8,677
Total debt	1,686	3,027	3,120	2,774	2,626	5,101	5,040	4,346	5,413	5,323
Paid-in capital	3,334	3,368	3,396	3,419	3,441	3,470	3,489	3,519	3,550	3,569
Retained earnings	936	1,440	1,693	2,077	2,608	3,162	3,719	4,563	5,915	6,402
Other comprehensive income	-131	-129	-144	-146	-158	-97.6	-38.5	-49	-13	60
Shareholders' equity	4,140	4,680	4,946	5,351	5,891	6,535	7,171	8,034	9,453	10,032
Minority interests	2.61	2.88	3	2.5	2.6	2.3	2.3	2	3	2
Total equity	4,143	4,683	4,949	5,353	5,893	6,537	7,173	8,036	9,456	10,034
Total liabilities and equity	7,301	8,993	9,551	10,132	10,581	14,393	14,994	15,125	18,170	18,711
Shares outstanding	62.9	62.9	62.5	62.4	62.3	62.4	62.1	61.8	61.1	60.3

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	425	713	470	612	721	703	867	1,170	1,996	1,137
Depreciation and amortization	285	297	344	372	394	452	506	513	573	637
Stock-based compensation	20.5	30.5	29.3	34.1	30	43	43	50	58	46
Deferred income tax	67.1	-239	85.1	29.4	43.8	92.2	-1	-36	-45	69
Change in receivables	-25.1	-29.3	-10.6	-50.4	6.1	-194	-12	31	81	-51
Change in inventory	-47.4	-79	-22	-27.7	-19.3	73.2	-132	-189	-52	-30
Cash from operations	689	658	705	966	1,050	1,138	991	1,528	1,459	1,785
Capital expenditures	-387	-410	-376	-394	-360	-423	-482	-650	-855	-807
Acquisitions	-175	-12.1	-1,642		-65.1	-3,109	11	0	-3,642	-685
Cash from investing	-555	-386	-1,948	-386	-410	-3,475	-484	459	-2,444	-1,588
Debt issued	560	2,409	1,000	625	628	2,897	0	0	2,758
Debt repaid	-449	-1,065	-910	-975	-777	-420	-54	-700	-1,690	-735
Stock issued	21.3	10.1	7.3	13.7	2.3	1.3	0.6	1.2
Share buybacks	-259	-100	-100	-98.2	-50	0	-150	-150	-450	-450
Dividends paid	-105	-109	-116	-130	-140	-148	-160	-174	-189	-197
Cash from financing	-252	1,125	-158	-604	-357	2,291	-407	-1,064	373	-800
Net change in cash	-118	1,396	-1,402	-23.9	283	-45.5	100	923	-612	-603
Free cash flow	302	247	329	573	690	715	509	878	604	978
Interest paid	73.7	78.9	137	128	114	105	165	159	158	229
Income taxes paid	124	156	28.9	102	115	103	201	292	382	192

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $484.30 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	28.2%	Gross profit / revenue.
Operating margin	20.6%	Operating income / revenue.
EBITDA margin	30.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	17.4%	Pre-tax income / revenue.
Net margin	36.7%	Net income / revenue.
FCF margin	12.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	22.7%	Cash from operations / revenue.
Effective tax rate	20.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	21.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	11.5%	Net income / average total assets.
Return on invested capital (ROIC)	6.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	6.9%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	10.6%	Capital expenditures / revenue.
D&A / revenue	10.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	8.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-0.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	5.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	15.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	9.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	8.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-42.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	6.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	7.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-32.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	6.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	8.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-43.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	9.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	9.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-42.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	10.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	10.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	22.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	21.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	11.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	61.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	24.3%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	7.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	5.9%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	8.5%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	7.7%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	6.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	11.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	11.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	3.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	7.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	12.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.41x	Current assets / current liabilities.
Quick ratio	0.65x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.06x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.52x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	27.9%	Total debt / total assets.
Liabilities / assets	45.8%	Total liabilities / total assets.
Net debt	$5.84B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.82x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	5.95x	Operating income / interest expense.
Working capital	$707.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	18.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$7.59B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.31x	Revenue / average total assets.
Fixed asset turnover	0.51x	Revenue / average property, plant and equipment.
Inventory turnover	4.11x	Cost of revenue / average inventory.
Days inventory	89 days	365 x average inventory / cost of revenue.
Receivables turnover	6.56x	Revenue / average receivables.
Days sales outstanding	56 days	365 x average receivables / revenue.
Days payables	27 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	118 days	Days inventory + days sales outstanding - days payables.
FCF conversion	33.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	46.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$40.81	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$111.11	Revenue / diluted weighted shares.
FCF per share	$13.46	Free cash flow / diluted weighted shares.
Operating cash flow per share	$25.23	Cash from operations / diluted weighted shares.
Book value per share	$192.27	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$126.34	Tangible book value / shares outstanding.
Cash per share	$1.87	(Cash + short-term investments) / shares outstanding.
Payout ratio	8.2%	Dividends paid / net income, when net income is positive.
Dividends / FCF	24.9%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	24.7%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$29.09B	Share price x shares outstanding.
Enterprise value	$34.93B	Market cap + total debt - cash - short-term investments.
P/E	11.8x	Market cap / net income. Only when net income is positive.
P/S	4.35x	Market cap / revenue.
P/B	2.52x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.83x	Market cap / tangible book value, when positive.
P/FCF	35.9x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	19.2x	Market cap / cash from operations, when positive.
EV/Sales	5.22x	Enterprise value / revenue.
EV/EBIT	25.3x	Enterprise value / operating income, when both are positive.
EV/EBITDA	16.9x	Enterprise value / EBITDA, when both are positive.
EV/FCF	43.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	2.8%	Free cash flow / market cap.
Earnings yield	8.4%	Net income / market cap (the inverse of P/E).
Dividend yield	0.7%	Dividends paid over the period / market cap.
Shareholder yield	1.4%	(Dividends paid + share buybacks) / market cap.
PEG	1.12x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was MARTIN MARIETTA MATERIALS INC's revenue in fiscal 2025?

MARTIN MARIETTA MATERIALS INC reported revenue of $6.15B for fiscal 2025, 8.6% higher than the year before.

Was MARTIN MARIETTA MATERIALS INC profitable in fiscal 2025?

Yes. Net income was $1.14B, a net margin of 18.5%.

How much free cash flow did MARTIN MARIETTA MATERIALS INC generate in fiscal 2025?

Cash from operations of $1.79B minus capital expenditures of $807.0M left free cash flow of $978.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to MARTIN MARIETTA MATERIALS INC